APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Selected research

Market Outlook & Growth Opportunities

Global Quetiapine Fumarate Market Outlook and Growth Opportunities 2026

26 December 2025199 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Read the full market overview

This report provides an overview of the global Quetiapine Fumarate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine Fumarate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine Fumarate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine Fumarate market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Fumarate Segment by Company

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy's

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Quetiapine Fumarate Segment by Type

Immediate Release Tablets

Extended Release Tablets

Quetiapine Fumarate Segment by Application

Adult

Others

Quetiapine Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Quetiapine Fumarate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Quetiapine Fumarate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Quetiapine Fumarate significant trends, drivers, influence factors in global and regions.

6. To analyze Quetiapine Fumarate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine Fumarate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quetiapine Fumarate industry.

Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Quetiapine Fumarate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Fumarate Industry Trends Table 2. Quetiapine Fumarate Industry Drivers Table 3. Quetiapine Fumarate Industry Opportunities and Challenges Table 4. Quetiapine Fumarate Industry Restraints Table 5. Global Quetiapine Fumarate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Quetiapine Fumarate Revenue Share by Company (2021-2026) Table 7. Global Quetiapine Fumarate Sales Volume by Company (t) & (2021-2026) Table 8. Global Quetiapine Fumarate Sales Volume Share by Company (2021-2026) Table 9. Global Quetiapine Fumarate Average Price (USD/kg) of Company (2021-2026) Table 10. Global Quetiapine Fumarate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Quetiapine Fumarate Key Company Manufacturing Base & Headquarters Table 12. Global Quetiapine Fumarate Company, Product Type & Application Table 13. Global Quetiapine Fumarate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immediate Release Tablets Table 18. Significant Companies of Extended Release Tablets Table 19. Global Quetiapine Fumarate Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Quetiapine Fumarate Sales Volume by Type (2021-2026) & (t) Table 21. Global Quetiapine Fumarate Sales Volume by Type (2027-2032) & (t) Table 22. Global Quetiapine Fumarate Sales Volume Share by Type (2021-2026) Table 23. Global Quetiapine Fumarate Sales Volume Share by Type (2027-2032) Table 24. Global Quetiapine Fumarate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Quetiapine Fumarate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Quetiapine Fumarate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Quetiapine Fumarate Sales Value Share by Type (2021-2026) Table 28. Global Quetiapine Fumarate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Table 30. Significant Companies of Others Table 31. Global Quetiapine Fumarate Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 32. Global Quetiapine Fumarate Sales Volume by Application (2021-2026) & (t) Table 33. Global Quetiapine Fumarate Sales Volume by Application (2027-2032) & (t) Table 34. Global Quetiapine Fumarate Sales Volume Share by Application (2021-2026) Table 35. Global Quetiapine Fumarate Sales Volume Share by Application (2027-2032) Table 36. Global Quetiapine Fumarate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Quetiapine Fumarate Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Quetiapine Fumarate Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Quetiapine Fumarate Sales Value Share by Application (2021-2026) Table 40. Global Quetiapine Fumarate Sales Value Share by Application (2027-2032) Table 41. Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global Quetiapine Fumarate Sales by Region (2021-2026) & (t) Table 43. Global Quetiapine Fumarate Sales Market Share by Region (2021-2026) Table 44. Global Quetiapine Fumarate Sales by Region (2027-2032) & (t) Table 45. Global Quetiapine Fumarate Sales Market Share by Region (2027-2032) Table 46. Global Quetiapine Fumarate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Quetiapine Fumarate Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Quetiapine Fumarate Sales Value Share by Region (2021-2026) Table 49. Global Quetiapine Fumarate Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Quetiapine Fumarate Sales Value Share by Region (2027-2032) Table 51. Global Quetiapine Fumarate Market Average Price (USD/kg) by Region (2021-2026) Table 52. Global Quetiapine Fumarate Market Average Price (USD/kg) by Region (2027-2032) Table 53. Global Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Table 54. Global Quetiapine Fumarate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 56. Global Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 57. Global Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 58. Global Quetiapine Fumarate Sales Market Share by Country (2027-2032) Table 59. Global Quetiapine Fumarate Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Quetiapine Fumarate Sales Value Market Share by Country (2021-2026) Table 61. Global Quetiapine Fumarate Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Quetiapine Fumarate Sales Value Market Share by Country (2027-2032) Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 66. AstraZeneca Quetiapine Fumarate Product Portfolio Table 67. AstraZeneca Recent Development Table 68. Intas Company Information Table 69. Intas Business Overview Table 70. Intas Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 71. Intas Quetiapine Fumarate Product Portfolio Table 72. Intas Recent Development Table 73. TAPI Company Information Table 74. TAPI Business Overview Table 75. TAPI Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. TAPI Quetiapine Fumarate Product Portfolio Table 77. TAPI Recent Development Table 78. Accord Company Information Table 79. Accord Business Overview Table 80. Accord Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. Accord Quetiapine Fumarate Product Portfolio Table 82. Accord Recent Development Table 83. Hexal Company Information Table 84. Hexal Business Overview Table 85. Hexal Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Hexal Quetiapine Fumarate Product Portfolio Table 87. Hexal Recent Development Table 88. Dr.Reddy's Company Information Table 89. Dr.Reddy's Business Overview Table 90. Dr.Reddy's Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. Dr.Reddy's Quetiapine Fumarate Product Portfolio Table 92. Dr.Reddy's Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. Lupin Quetiapine Fumarate Product Portfolio Table 97. Lupin Recent Development Table 98. Sun Pharmaceutical Company Information Table 99. Sun Pharmaceutical Business Overview Table 100. Sun Pharmaceutical Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Sun Pharmaceutical Quetiapine Fumarate Product Portfolio Table 102. Sun Pharmaceutical Recent Development Table 103. Hunan Dongting Pharm Company Information Table 104. Hunan Dongting Pharm Business Overview Table 105. Hunan Dongting Pharm Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio Table 107. Hunan Dongting Pharm Recent Development Table 108. SuZhou NO.4 Phamaceutical Factory Company Information Table 109. SuZhou NO.4 Phamaceutical Factory Business Overview Table 110. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio Table 112. SuZhou NO.4 Phamaceutical Factory Recent Development Table 113. Fuan Pharmaceutical Company Information Table 114. Fuan Pharmaceutical Business Overview Table 115. Fuan Pharmaceutical Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio Table 117. Fuan Pharmaceutical Recent Development Table 118. Zhejiang Supor Pharmaceuticals Company Information Table 119. Zhejiang Supor Pharmaceuticals Business Overview Table 120. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio Table 122. Zhejiang Supor Pharmaceuticals Recent Development Table 123. Zhejiang Huahai Pharmaceutical Company Information Table 124. Zhejiang Huahai Pharmaceutical Business Overview Table 125. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio Table 127. Zhejiang Huahai Pharmaceutical Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Quetiapine Fumarate Distributors List Table 131. Quetiapine Fumarate Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Product Image Figure 2. Global Quetiapine Fumarate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Fumarate Sales (2021-2032) & (t) Figure 5. Global Quetiapine Fumarate Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Quetiapine Fumarate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immediate Release Tablets Image Figure 10. Extended Release Tablets Image Figure 11. Global Quetiapine Fumarate Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Quetiapine Fumarate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Quetiapine Fumarate Sales Volume Share by Type (2021-2032) Figure 14. Global Quetiapine Fumarate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Quetiapine Fumarate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Quetiapine Fumarate Sales Value Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Others Image Figure 19. Global Quetiapine Fumarate Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global Quetiapine Fumarate Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Quetiapine Fumarate Sales Volume Share by Application (2021-2032) Figure 22. Global Quetiapine Fumarate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Quetiapine Fumarate Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Quetiapine Fumarate Sales Value Share by Application (2021-2032) Figure 25. Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global Quetiapine Fumarate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Quetiapine Fumarate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Quetiapine Fumarate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 30. North America Quetiapine Fumarate Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Quetiapine Fumarate Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Quetiapine Fumarate Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 36. South America Quetiapine Fumarate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Quetiapine Fumarate Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Quetiapine Fumarate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Quetiapine Fumarate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Quetiapine Fumarate Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Quetiapine Fumarate Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release Tablets
  • Extended Release Tablets
Applications
  • Adult
  • Others
Companies covered
  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quetiapine Fumarate Sales Value (2021-2032)
  4. 1.2.2 Global Quetiapine Fumarate Sales Volume (2021-2032)
  5. 1.2.3 Global Quetiapine Fumarate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Quetiapine Fumarate Market Dynamics
  1. 2.1 Quetiapine Fumarate Industry Trends
  2. 2.2 Quetiapine Fumarate Industry Drivers
  3. 2.3 Quetiapine Fumarate Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Industry Restraints
3 Quetiapine Fumarate Market by Company
  1. 3.1 Global Quetiapine Fumarate Company Revenue Ranking in 2025
  2. 3.2 Global Quetiapine Fumarate Revenue by Company (2021-2026)
  3. 3.3 Global Quetiapine Fumarate Sales Volume by Company (2021-2026)
  4. 3.4 Global Quetiapine Fumarate Average Price by Company (2021-2026)
  5. 3.5 Global Quetiapine Fumarate Company Ranking (2024-2026)
  6. 3.6 Global Quetiapine Fumarate Company Manufacturing Base and Headquarters
  7. 3.7 Global Quetiapine Fumarate Company Product Type and Application
  8. 3.8 Global Quetiapine Fumarate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Quetiapine Fumarate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Quetiapine Fumarate Market by Type
  1. 4.1 Quetiapine Fumarate Type Introduction
  2. 4.1.1 Immediate Release Tablets
  3. 4.1.2 Extended Release Tablets
  4. 4.2 Global Quetiapine Fumarate Sales Volume by Type
  5. 4.2.1 Global Quetiapine Fumarate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Quetiapine Fumarate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Quetiapine Fumarate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Quetiapine Fumarate Sales Value by Type
  9. 4.3.1 Global Quetiapine Fumarate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Quetiapine Fumarate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Quetiapine Fumarate Sales Value Share by Type (2021-2032)
5 Quetiapine Fumarate Market by Application
  1. 5.1 Quetiapine Fumarate Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Others
  4. 5.2 Global Quetiapine Fumarate Sales Volume by Application
  5. 5.2.1 Global Quetiapine Fumarate Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Quetiapine Fumarate Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Quetiapine Fumarate Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Quetiapine Fumarate Sales Value by Application
  9. 5.3.1 Global Quetiapine Fumarate Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Quetiapine Fumarate Sales Value by Application (2021-2032)
  11. 5.3.3 Global Quetiapine Fumarate Sales Value Share by Application (2021-2032)
6 Quetiapine Fumarate Regional Sales and Value Analysis
  1. 6.1 Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Fumarate Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Fumarate Sales by Region: 2021-2026
  4. 6.2.2 Global Quetiapine Fumarate Sales by Region (2027-2032)
  5. 6.3 Global Quetiapine Fumarate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Quetiapine Fumarate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Quetiapine Fumarate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Quetiapine Fumarate Sales Value by Region (2027-2032)
  9. 6.5 Global Quetiapine Fumarate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Quetiapine Fumarate Sales Value (2021-2032)
  12. 6.6.2 North America Quetiapine Fumarate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Quetiapine Fumarate Sales Value (2021-2032)
  15. 6.7.2 Europe Quetiapine Fumarate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Quetiapine Fumarate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Quetiapine Fumarate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Quetiapine Fumarate Sales Value (2021-2032)
  21. 6.9.2 South America Quetiapine Fumarate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Quetiapine Fumarate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Quetiapine Fumarate Sales Value Share by Country, 2025 VS 2032
7 Quetiapine Fumarate Country-level Sales and Value Analysis
  1. 7.1 Global Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Quetiapine Fumarate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Quetiapine Fumarate Sales by Country (2021-2032)
  4. 7.3.1 Global Quetiapine Fumarate Sales by Country (2021-2026)
  5. 7.3.2 Global Quetiapine Fumarate Sales by Country (2027-2032)
  6. 7.4 Global Quetiapine Fumarate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Quetiapine Fumarate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Quetiapine Fumarate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Quetiapine Fumarate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Quetiapine Fumarate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Quetiapine Fumarate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Intas
  8. 8.2.1 Intas Company Information
  9. 8.2.2 Intas Business Overview
  10. 8.2.3 Intas Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Intas Quetiapine Fumarate Product Portfolio
  12. 8.2.5 Intas Recent Developments
  13. 8.3 TAPI
  14. 8.3.1 TAPI Company Information
  15. 8.3.2 TAPI Business Overview
  16. 8.3.3 TAPI Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TAPI Quetiapine Fumarate Product Portfolio
  18. 8.3.5 TAPI Recent Developments
  19. 8.4 Accord
  20. 8.4.1 Accord Company Information
  21. 8.4.2 Accord Business Overview
  22. 8.4.3 Accord Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Accord Quetiapine Fumarate Product Portfolio
  24. 8.4.5 Accord Recent Developments
  25. 8.5 Hexal
  26. 8.5.1 Hexal Company Information
  27. 8.5.2 Hexal Business Overview
  28. 8.5.3 Hexal Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hexal Quetiapine Fumarate Product Portfolio
  30. 8.5.5 Hexal Recent Developments
  31. 8.6 Dr.Reddy's
  32. 8.6.1 Dr.Reddy's Company Information
  33. 8.6.2 Dr.Reddy's Business Overview
  34. 8.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
  36. 8.6.5 Dr.Reddy's Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Quetiapine Fumarate Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 Sun Pharmaceutical
  44. 8.8.1 Sun Pharmaceutical Company Information
  45. 8.8.2 Sun Pharmaceutical Business Overview
  46. 8.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Recent Developments
  49. 8.9 Hunan Dongting Pharm
  50. 8.9.1 Hunan Dongting Pharm Company Information
  51. 8.9.2 Hunan Dongting Pharm Business Overview
  52. 8.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
  54. 8.9.5 Hunan Dongting Pharm Recent Developments
  55. 8.10 SuZhou NO.4 Phamaceutical Factory
  56. 8.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
  57. 8.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
  58. 8.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
  60. 8.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
  61. 8.11 Fuan Pharmaceutical
  62. 8.11.1 Fuan Pharmaceutical Company Information
  63. 8.11.2 Fuan Pharmaceutical Business Overview
  64. 8.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
  66. 8.11.5 Fuan Pharmaceutical Recent Developments
  67. 8.12 Zhejiang Supor Pharmaceuticals
  68. 8.12.1 Zhejiang Supor Pharmaceuticals Company Information
  69. 8.12.2 Zhejiang Supor Pharmaceuticals Business Overview
  70. 8.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
  72. 8.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
  73. 8.13 Zhejiang Huahai Pharmaceutical
  74. 8.13.1 Zhejiang Huahai Pharmaceutical Company Information
  75. 8.13.2 Zhejiang Huahai Pharmaceutical Business Overview
  76. 8.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
  78. 8.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Fumarate Value Chain Analysis
  2. 9.1.1 Quetiapine Fumarate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Fumarate Sales Mode & Process
  6. 9.2 Quetiapine Fumarate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Fumarate Distributors
  9. 9.2.3 Quetiapine Fumarate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst